NanoVibronix's subsidiary receives patent approval
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Patent Issuance: NanoVibronix's subsidiary, ENvue Medical, received U.S. Patent No. 12,402,953 B2 on September 2, which protects a method for overlaying electromagnetic navigation data onto real-time medical imaging.
Technological Impact: The patented technology aims to assist clinicians in visualizing the live path of feeding tubes or catheters on medical images, enhancing procedural accuracy and safety.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
